Monsanto Company today announced it has completed the purchase of
substantially all of the assets, and assumption of certain liabilities,
of Rosetta Green Ltd.

Rosetta Green develops improved plant traits for agriculture using RNA
technology. Rosetta Green experts specialize in the identification and
use of unique genes to guide key processes in major crops including
corn, soybeans and cotton. The company was formed in 2010 and is based
in Rehovot, Israel, at the heart of one of Israel's major science
centers. The company's Israel operations will remain intact and all
Rosetta Green employees have accepted roles with Monsanto.

"We're pleased to welcome the Rosetta Green team and look forward to
working together on possible new applications of this exciting
technology, which complements our existing research platforms," said
Steve Padgette, Ph.D., Monsanto R&D investment lead.

"All of us at Rosetta Green are excited to begin our work with
Monsanto," said Limor Zur-Stoller, Rosetta Green's Chief Financial
Officer. "Israel continues to emerge as a leader in cutting-edge
technologies, and this is a great vote of confidence in our research
work and scientists."

Following the receipt of required approvals from Israel regulators and
the satisfaction of other customary closing conditions, the transaction

About Monsanto Company

Monsanto Company is a leading global provider of technology-based
solutions and agricultural products that improve farm productivity and
food quality. Monsanto remains focused on enabling both small-holder and
large-scale farmers to produce more from their land while conserving
more of our world's natural resources such as water and energy. To learn
more about our business and our commitments, please visit:
Follow our business on Twitter® at,
on the company blog, Beyond the Rows at,
or subscribe to our News
Release RSS Feed